COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 2253: Articles 22521-22530  | Next

Convalescent Plasma for COVID-19: A multicenter, randomized clinical trial
Avendano-Sola, C., Ramos-Martinez, A., Munez-Rubio, E., Ruiz-Antoran, B., Malo de Molina, R., Torres, F., Fernandez-Cruz, A., Callejas-Diaz, A., Calderon, J., Payares-Herrera, C., Salcedo, I., Romera, I., Lora-Tamayo, J., Mancheno-Losa, M., Paciello, M. L., Villegas, C., Estrada, V., Saez-Serrano, I., Porras-Leal, M. L., Jarilla-Fernandez, M. d. C., Pano-Pardo, J. R., Moreno-Chulilla, J. A., Arrieta-Aldea, I., Bosch, A., Belhassen-Garcia, M., Lopez-Villar, O., Ramos-Garrido, A., Blanco, L., Madrigal, M. E., Contreras, E., Muniz-Diaz, E., Domingo-Morera, J. M., Casas-Flecha, I., Perez-Olmeda, M., Garcia-Perez, J., Alcami, J., Bueno, J. L., Duarte, R. F.
10.1101/2020.08.26.20182444 — Posted: 2020-09-01
The importance of saturating density dependence for predicting SARS-CoV-2 resurgence
Nightingale, E., Brady, O. J., Yakob, L.
10.1101/2020.08.28.20183921 — Posted: 2020-09-01
Risk factors for severe outcomes of COVID-19: a rapid review
Wingert, A., Pillay, J., Gates, M., Guitard, S., Rahman, S., Beck, A., Vandermeer, B., Hartling, L.
10.1101/2020.08.27.20183434 — Posted: 2020-09-01
Implementation and validation of a pooling strategy for a sustainable screening campaign for the presence of SARS-CoV-2.
Cesselli, D., Bulfoni, M., Marzinotto, S., Marcon, B., Cmet, S., Migotti, A., Cussigh, A. R., Martinella, R., Pipan, C., Beltrami, A. P., Curcio, F.
10.1101/2020.08.28.20174946 — Posted: 2020-09-01
A Comparison of Covid-19 Patient Characteristics Before versus After Partial Lockdown in Vietnam
Vo, H.-L., Nguyen, H. A. S., Nguyen, T. P. T., Nguyen, K. N., Vu, K.-D., Anh, V. D. T., Nguyen, T. T., Hoang, M. T., Nguyen, T. H. T., Vu, G. T., Le, H. T.
10.1101/2020.08.27.20183616 — Posted: 2020-09-01
Sex-based clinical and immunological differences in COVID-19
Li, K., Huang, B., Cai, Y., Wang, Z., Li, L., Wu, L., Zhu, M., Li, J., Wang, Z., Wu, M., Li, W., Wu, W., Zhang, L., Xia, X., Wang, S., Wang, Q.
10.1101/2020.08.29.20126201 — Posted: 2020-09-01
Social Determinants Associated with COVID-19 Mortality in the United States
Debopadhaya, S., Sprague, A. D., Mou, H., Benavides, T. L., Ahn, S. M., Reschke, C. A., Erickson, J. S., Bennett, K. P.
10.1101/2020.08.28.20183848 — Posted: 2020-09-01
Population-based seroprevalence of SARS-CoV-2 is more than halfway through the herd immunity threshold in the State of Maranhao, Brazil
Silva, A. A. M. d., Lima Neto, L. G., Azevedo, C. d. M. P. e. S. d., Costa, L. M. M. d., Braganca, M. L. B. M., Barros Filho, A. K. D., Wittlin, B. B., Souza, B. F. d., Oliveira, B. L. C. A. d., Carvalho, C. A. d., Thomaz, E. B. A. F., Simoes Neto, E. A., Leite Junior, J. F., Cosme, L. M. S. S., Campos, M. A. G., Queiroz, R. C. d. S., Costa, S. S., Carvalho, V. A. d., Simoes, V. M. F., Alves, M. T. S. S. d. B. e., Santos, A. M. d.
10.1101/2020.08.28.20180463 — Posted: 2020-09-01 Discussion: Onsite
Backward and Hopf bifurcation analysis of an SEIRS COVID-19 epidemic model with saturated incidence and saturated treatment response
Oluyori, D. A., Perez, A. G. C., Victor, A. O., Akram, M.
10.1101/2020.08.28.20183723 — Posted: 2020-09-01
A world apart: levels and factors of excess mortality due to COVID-19 in care homes. The case of Wallonia - Belgium.
Hardy, O. J., Dubourg, D., Bourguignon, M., Dellicour, S., Eggerickx, T., Gilbert, M., Sanderson, J.-P., Scohy, A., Vandael, E., Decroly, J.-M.
10.1101/2020.08.29.20183210 — Posted: 2020-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).